Equities

Octave Specialty Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Octave Specialty Group Inc

Actions
  • Price (EUR)4.76
  • Today's Change-0.06 / -1.24%
  • Shares traded101.00
  • 1 Year change-57.88%
  • Beta0.8239
Data delayed at least 15 minutes, as of Feb 12 2026 07:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Octave Specialty Group, Inc. is a global specialty insurance company that builds, buys, and scales niche insurance distribution and underwriting businesses. It provides strategic direction, risk oversight, data and technology solutions, and capital support to MGA businesses operating across the U.S., U.K., and Bermuda. Its build-and-buy strategy is executed by its incubation division, Octave Ventures, and its acquisition division, Octave Partners. At Octave Ventures, it helps specialty underwriters to set up their own company, leveraging its resources. It offers funding, infrastructure, risk capital, and A+ rated paper as well as experienced guidance and support to underwriters looking to launch their own MGAs. Octave Partners identifies high-performing MGAs that would benefit from its partnership and add value to its expanding portfolio. To facilitate growth, it provides expertise, technology, distribution and capacity relationships, expansion and cross-company sales opportunities.

  • Revenue in USD (TTM)84.40m
  • Net income in USD-76.49m
  • Incorporated1991
  • Employees380.00
  • Location
    Octave Specialty Group IncOne World Trade CenterOne World Trade CenterNEW YORK 10007United StatesUSA
  • Phone+1 (212) 658-7470
  • Fax+1 (212) 208-3414
  • Websitehttps://octavegroup.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
OSG:NYQ since
announced
Transaction
value
ArmadaCare Executive HealthDeal completed29 Sep 202529 Sep 2025Deal completed-39.41%250.00m
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.